Updated:
Théa Open Innovation
Théa Open Innovation is the single-family office of the Théa family, investing in healthcare and technology from Montreal and Clermont-Ferrand.
Théa Open Innovation
Théa Open Innovation is the investment arm of the Théa family, whose wealth originates from Théa Pharmaceuticals, a French ophthalmic company. Founded in the 2010s, the family office maintains dual headquarters in Montreal and Clermont-Ferrand, reflecting its cross-continental focus. The firm invests across healthcare services, life sciences, digital health, and enterprise software. It seeks early-stage opportunities, often participating in seed and Series A rounds. Known portfolio companies include Oculis and other ophthalmology-related startups, though specific deals are not widely publicized (per public record). Geographic focus spans North America and Europe, with a particular emphasis on Quebec and France. Théa Open Innovation operates with a lean team, though exact professional count is undisclosed. It maintains a philanthropic posture aligned with the family's legacy, though no separate foundation is publicly named. No recent operational events have been reported in the last 24 months. Structurally, Théa Open Innovation distinguishes itself by its explicit 'open innovation' mandate — investing alongside external venture firms rather than exclusively deploying family capital. This hybrid model allows the office to co-invest with institutional VCs while retaining family control over strategic direction.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Montreal
Corporate office
Montreal, Quebec, Canada
Additional offices
Clermont-Ferrand, France
Principals
Théa family
Undisclosed
Sector focus
Frequently asked questions
Who runs investment decisions at Théa Open Innovation?
The office is managed by the Théa family, whose wealth derives from Théa Pharmaceuticals. Named investment professionals are not publicly disclosed, but the firm operates with a lean, family-led decision structure.
How does Théa Open Innovation source proprietary deal flow?
The firm leverages its 'open innovation' model, co-investing alongside venture capital firms and corporate partners. It also taps into the healthcare and technology ecosystems in Quebec and France.
Is Théa Open Innovation structured as a single family office or does it operate more like a venture firm?
It is a single-family office with an open-innovation mandate, investing both directly and through syndicates alongside external VCs.
Does Théa Open Innovation participate in fund commitments or only direct deals?
The firm engages primarily in direct investments and co-investments, rather than committing to third-party funds.
What investment stages does Théa Open Innovation typically target?
The firm focuses on early-stage opportunities, including seed and Series A rounds, in healthcare and technology.
Which sectors does Théa Open Innovation explicitly avoid?
The firm does not publicly disclose excluded sectors, but its focus on healthcare and technology suggests it avoids heavy industrial or extractive industries.
Does Théa Open Innovation maintain philanthropic structures, and how are they separated?
The family is linked to Théa Pharmaceuticals' corporate social responsibility initiatives, but a separately branded foundation is not publicly documented.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: